Optibiotix Health Share Discussion Threads

[john henry] 08/11/2017 08:16

Unfortunately at present, investors, the market just isnt listening.Volume and interest has been very low despite some excellent news.

[bobdown2] 08/11/2017 08:16

Bought some....5.000 I am very suprised at the lack of buying. I expect some want a diagram to go with the r.n.s.

[wreckage] 08/11/2017 08:03

ImmunBiome.... whats that all about? have we found another holy grail. surely we have not discovered the biome that enhances the immune defences. this is mind boggling if we have. Elrico can you contact SOH to see if there is any expansion on this line of investigation?

Wreckage

[elrico] 08/11/2017 08:01

General Mills and Kellogg's via CII anyone? Neither US company have the ability to manufacture their own ingredients. I'm pretty confident they get their ingredients from CII.

Knighton Foods - commercial basket case ;)

[owenmo] 08/11/2017 07:55

There’s one thing we lths share with mmouse: a sense of anticipation and of excitement when an rns is flagged.

[shrewdmole] 08/11/2017 07:52

Well being section in boots?

[rafboy] 08/11/2017 07:52

Wow, so many uses and so many revenue streams coming our way. Love it.

[tightfist] 08/11/2017 07:45

This latest RNS could well be the one that completes the share price consolidation to close today at/above 74p, then we should finally be off and away on the journey North. The two small retracements during this last week have been on notably low volume.Oh....... And I love the products news!

[jestercat2] 08/11/2017 07:33

I love the move into coffee and tea blends!

[parob] 08/11/2017 07:15

We anticipate SlimBiome(R) being the first in a family of products to include: ImmunBiome, WellBiome, OptiBiome(R) and CardioBiome(R), developed.Lots of new ingredients announced! I get the impression SlimBiome could become more valuable than initially envisaged.Must admit I am loving these weekly RNS!

[deeppockets] 08/11/2017 07:07

Yet another positive update and more potential revenue streams. Talk of cookies and tortillas suggests the US market! All coming together.

[chrisg11] 08/11/2017 00:19

Loungeact

Can't understand any of that loungeact so someone else needs to translate.

If I understand elrico correctly I have been after a study that's not actually been published yet so no wonder I can't find it!

I'm only teasing elrico a bit over wanting to see peer reviews because he mentions them so often. I doubt the review comments are available anyway.

Peer reviewing before publication. I suppose is the standard but does have its failings and journals seem to like it.

I simply want to have a look at the study write up when it's published and see where these relatively low percentage improvements come from in BP and cholesterol and to form a practical clinical view on this potentially exciting development.

I am not a detractor of the science as you and others believe.

The science at times is a bit complex even for me but I am mainly interested in how this will translate into 'clinical benefit' to people compared with pharmaceuticals.

I've mentioned it before and even the enthusiasts didn't seem to realise it that if indeed a food additive/probiotic with or without a catalyst can significantly and with proven clinical preventative benefit lower both cholesterol and BP it is one of the discoveries of the century.

I am a guarded enthusiast and I think some on here have got me all wrong following my alternative but more accurate analysis of Dr Adnan's cholesterol results!

I cannot wait to see if the good doctor will give us his next cholesterol result because that may be the moment of truth!

[elrico] 07/11/2017 23:57

Paul - You ask a very good question. I gather our resident Victor Meldrew is continuing with his "I demand to see the peer review" and I am not going to have the wool pulled over my eyes by man nor beast, and definitely by that lapdog Elrico. Perhaps Chris is desperate to portray he has a superior grasp of the science behind the LP-LDL and wants to impart his wisdom. Perhaps Chris has some advise he wishes to share with the authors, Prof Glen Gibson and Pro John Swann.

I opened the door for anyone wanting info. All he has to do is PM me with his email address and I'll furnish him with everything I have on the subject, including the documentation used at the Probiota conference which was used in the peer review.

Has Chris got round to explaining where he magicked my 6 figure investment from? No! Just as I suspected. It is like asking Michaelmouse to explain his accounting deceptions I debunked - they remain unanswered also. Perhaps I'll get answers to all of them in a Christmas card.

[nicktopten] 07/11/2017 21:53

Thanks DC..... there are a few words in that Ive not come across before... and the pictures? !! Given time, I might scratch the surface though! Just been helping my son with GCSE Biology, so thanks again for the heads up!
Seriously though... it looks like a fantastically well laid out piece of work and anyone with a background in biochemistry would lap it up, Im sure....

[loungeact] 07/11/2017 20:08

Chrisg11 has a lot of expertise. He'll translate all this for us.

[incanus] 07/11/2017 19:54

Wow, that must be the science bit dc.

[elrico] 07/11/2017 18:25

Rayrac - Why don't you do us all a favour by sharing your woes with BPRG/Meldex and compare it with your humble opinion on the parallels with OPTI. I'm sure it would make for an interesting discussion. Thus far the only success you have is making yourself look ignorant to new science, new niche areas the world over is getting excited about and you seem oblivious to it.

As for the peer review...there is some background on it here:

The peer review is in a scientific publication (can't remember it but you don't care anyway) which is a subscription service but believe it becomes available online in a few weeks. In the meantime this is a peer reviewed abstract of the study carried out by Reading University presented at ProBiota ( )and an accompanying scientific poster. Note: authors such as Prof Glenn Gibson and Pro John Swann are LEADERS in their field and as leading academics would not be associated with poorly conducted, poorly analysed, or studies with a commercial bias. This abstract was accompanied by a poster which won the best poster competition.

The observant PI will note that there is a lag period between the end of a study and the data being reported, because it goes through an independent peer review process BEFORE publication to ensure SCIENTIFIC VALIDITY of methodology, data collection and analysis, and reporting. This process is robust thus given OPTI confidence in the data and is in addition to the peer review process which takes place before publication of any result at scientific conferences.

You will always get detractors and commentators who want to blur the science for their own purposes as can be seen with the debate on climate change. It is perfectly natural to be sceptical of new science, especially ahead of commercial process. However, those that do attempt to detract from the bleeding obvious, do so at their own costs, not mine and those that had done their own research and happened upon the same conclusion I have; in that OPTI has been significantly derisked in 2017, but with a mere 5 months of transition from R&D to commercial there remains room for sceptics until they see the money. Fine, no issue with that either, we have our own risk thresholds. However, simply screaming fraud at the top of your lungs in a library for attention then running out the door giggling - try some reasoned debating based on FACTS not childish behaviour.

I have the abstract and poster mentioned. Anyone wanting them only need to PM or email me.

[1bokke] 07/11/2017 17:54

Hey rayrac how's Ukog doing?